US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 12.750
  • -0.060-0.47%
Close Dec 13 16:00 ET
  • 13.200
  • +0.450+3.53%
Post 20:01 ET
1.29BMarket Cap-13.14P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
236.93%50.75M
-15.78%-49.13M
-91.38%-49.73M
-33.66%-146.85M
-17.17%-41.37M
-59.66%-37.06M
-42.45%-42.43M
-20.51%-25.99M
-126.36%-109.87M
-168.13%-35.31M
Net income from continuing operations
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
Operating gains losses
--0
----
----
----
----
----
----
----
----
----
Depreciation and amortization
653.54%746K
343.48%408K
30.34%116K
-27.87%383K
-42.78%103K
-40.00%99K
-30.83%92K
67.92%89K
166.83%531K
252.94%180K
Other non cash items
----
----
----
--3M
--0
----
----
----
----
----
Change In working capital
-5,254.56%-52.21M
5,872.13%50.74M
-83.74%1.22M
43.48%9.42M
412.84%3.8M
-114.19%-975K
-189.79%-879K
10,622.54%7.47M
143.56%6.56M
-133.38%-1.22M
-Change in receivables
--441K
----
----
----
----
--0
----
----
----
----
-Change in inventory
---2.55M
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
191.15%752K
-56.80%-3.87M
-35.85%884K
-262.53%-3.07M
-311.15%-1.16M
-154.93%-825K
25.78%-2.47M
223.47%1.38M
77.61%-846K
-48.40%547K
-Change in payables and accrued expense
-120,139.13%-55.31M
3,696.85%63.98M
-92.91%439K
66.17%12.89M
416.57%5.06M
-100.85%-46K
-61.42%1.69M
1,481.47%6.19M
16.54%7.76M
-161.31%-1.6M
-Change in other current liabilities
43.27%-59K
-11.11%-110K
-12.50%-108K
-16.71%-405K
34.97%-106K
-52.94%-104K
-47.76%-99K
-95.92%-96K
-90.66%-347K
-482.14%-163K
Cash from discontinued investing activities
Operating cash flow
236.93%50.75M
-15.78%-49.13M
-91.38%-49.73M
-33.66%-146.85M
-17.17%-41.37M
-59.66%-37.06M
-42.45%-42.43M
-20.51%-25.99M
-126.36%-109.87M
-168.13%-35.31M
Investing cash flow
Cash flow from continuing investing activities
-176.14%-67.7M
-15.87%17.06M
897.71%89.29M
150.33%128.38M
1,474.66%30.38M
136.02%88.92M
438.07%20.27M
-74,520.00%-11.19M
-3,088.43%-255.07M
-2.21M
Net PPE purchase and sale
-1,665.85%-724K
82.55%-26K
--0
-761.54%-224K
---8K
-925.00%-41K
-2,028.57%-149K
-73.33%-26K
---26K
--0
Net intangibles purchase and sale
-1,733.33%-55M
----
----
---3M
--0
---3M
----
----
--0
--0
Net investment purchase and sale
-113.02%-11.98M
-461.44%-73.82M
899.57%89.29M
151.60%131.6M
1,475.02%30.39M
137.25%91.96M
440.95%20.42M
---11.17M
---255.05M
---2.21M
Cash from discontinued investing activities
Investing cash flow
-176.14%-67.7M
-15.87%17.06M
897.71%89.29M
150.33%128.38M
1,474.66%30.38M
136.02%88.92M
438.07%20.27M
-74,520.00%-11.19M
-3,088.43%-255.07M
---2.21M
Financing cash flow
Cash flow from continuing financing activities
173,895.65%200.1M
-99.20%1.3M
-95.95%48K
-1.15%164M
-68.87%597K
-94.40%115K
0.11%162.1M
1.18M
-44.16%165.9M
503.14%1.92M
Net common stock issuance
--178.18M
----
----
-0.12%161.41M
--0
--0
----
----
-3.25%161.61M
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
18,959.13%21.92M
87.43%1.3M
-95.95%48K
-39.69%2.59M
-68.87%597K
-94.40%115K
116.25%692K
--1.18M
1,249.37%4.29M
503.14%1.92M
Cash from discontinued financing activities
Financing cash flow
173,895.65%200.1M
-99.20%1.3M
-95.95%48K
-1.15%164M
-68.87%597K
-94.40%115K
0.11%162.1M
--1.18M
-44.16%165.9M
503.14%1.92M
Net cash flow
Beginning cash position
26.64%239.62M
448.82%270.39M
170.68%230.78M
-70.01%85.26M
99.55%241.18M
-51.34%189.21M
-81.25%49.27M
-70.01%85.26M
550.18%284.31M
-59.33%120.86M
Current changes in cash
252.43%183.15M
-121.99%-30.78M
210.04%39.61M
173.11%145.52M
70.80%-10.4M
119.39%51.97M
10.94%139.94M
-66.81%-35.99M
-182.74%-199.05M
-177.04%-35.6M
End cash Position
75.29%422.77M
26.64%239.62M
448.82%270.39M
170.68%230.78M
170.68%230.78M
99.55%241.18M
-51.34%189.21M
-81.25%49.27M
-70.01%85.26M
-70.01%85.26M
Free cash flow
87.61%-4.97M
-55.60%-66.26M
-91.18%-49.73M
-36.56%-150.08M
-17.19%-41.38M
-72.73%-40.11M
-42.92%-42.58M
-20.54%-26.01M
-94.38%-109.9M
-168.13%-35.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 236.93%50.75M-15.78%-49.13M-91.38%-49.73M-33.66%-146.85M-17.17%-41.37M-59.66%-37.06M-42.45%-42.43M-20.51%-25.99M-126.36%-109.87M-168.13%-35.31M
Net income from continuing operations 180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M
Operating gains losses --0------------------------------------
Depreciation and amortization 653.54%746K343.48%408K30.34%116K-27.87%383K-42.78%103K-40.00%99K-30.83%92K67.92%89K166.83%531K252.94%180K
Other non cash items --------------3M--0--------------------
Change In working capital -5,254.56%-52.21M5,872.13%50.74M-83.74%1.22M43.48%9.42M412.84%3.8M-114.19%-975K-189.79%-879K10,622.54%7.47M143.56%6.56M-133.38%-1.22M
-Change in receivables --441K------------------0----------------
-Change in inventory ---2.55M------------------0----------------
-Change in prepaid assets 191.15%752K-56.80%-3.87M-35.85%884K-262.53%-3.07M-311.15%-1.16M-154.93%-825K25.78%-2.47M223.47%1.38M77.61%-846K-48.40%547K
-Change in payables and accrued expense -120,139.13%-55.31M3,696.85%63.98M-92.91%439K66.17%12.89M416.57%5.06M-100.85%-46K-61.42%1.69M1,481.47%6.19M16.54%7.76M-161.31%-1.6M
-Change in other current liabilities 43.27%-59K-11.11%-110K-12.50%-108K-16.71%-405K34.97%-106K-52.94%-104K-47.76%-99K-95.92%-96K-90.66%-347K-482.14%-163K
Cash from discontinued investing activities
Operating cash flow 236.93%50.75M-15.78%-49.13M-91.38%-49.73M-33.66%-146.85M-17.17%-41.37M-59.66%-37.06M-42.45%-42.43M-20.51%-25.99M-126.36%-109.87M-168.13%-35.31M
Investing cash flow
Cash flow from continuing investing activities -176.14%-67.7M-15.87%17.06M897.71%89.29M150.33%128.38M1,474.66%30.38M136.02%88.92M438.07%20.27M-74,520.00%-11.19M-3,088.43%-255.07M-2.21M
Net PPE purchase and sale -1,665.85%-724K82.55%-26K--0-761.54%-224K---8K-925.00%-41K-2,028.57%-149K-73.33%-26K---26K--0
Net intangibles purchase and sale -1,733.33%-55M-----------3M--0---3M----------0--0
Net investment purchase and sale -113.02%-11.98M-461.44%-73.82M899.57%89.29M151.60%131.6M1,475.02%30.39M137.25%91.96M440.95%20.42M---11.17M---255.05M---2.21M
Cash from discontinued investing activities
Investing cash flow -176.14%-67.7M-15.87%17.06M897.71%89.29M150.33%128.38M1,474.66%30.38M136.02%88.92M438.07%20.27M-74,520.00%-11.19M-3,088.43%-255.07M---2.21M
Financing cash flow
Cash flow from continuing financing activities 173,895.65%200.1M-99.20%1.3M-95.95%48K-1.15%164M-68.87%597K-94.40%115K0.11%162.1M1.18M-44.16%165.9M503.14%1.92M
Net common stock issuance --178.18M---------0.12%161.41M--0--0---------3.25%161.61M--0
Net preferred stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees 18,959.13%21.92M87.43%1.3M-95.95%48K-39.69%2.59M-68.87%597K-94.40%115K116.25%692K--1.18M1,249.37%4.29M503.14%1.92M
Cash from discontinued financing activities
Financing cash flow 173,895.65%200.1M-99.20%1.3M-95.95%48K-1.15%164M-68.87%597K-94.40%115K0.11%162.1M--1.18M-44.16%165.9M503.14%1.92M
Net cash flow
Beginning cash position 26.64%239.62M448.82%270.39M170.68%230.78M-70.01%85.26M99.55%241.18M-51.34%189.21M-81.25%49.27M-70.01%85.26M550.18%284.31M-59.33%120.86M
Current changes in cash 252.43%183.15M-121.99%-30.78M210.04%39.61M173.11%145.52M70.80%-10.4M119.39%51.97M10.94%139.94M-66.81%-35.99M-182.74%-199.05M-177.04%-35.6M
End cash Position 75.29%422.77M26.64%239.62M448.82%270.39M170.68%230.78M170.68%230.78M99.55%241.18M-51.34%189.21M-81.25%49.27M-70.01%85.26M-70.01%85.26M
Free cash flow 87.61%-4.97M-55.60%-66.26M-91.18%-49.73M-36.56%-150.08M-17.19%-41.38M-72.73%-40.11M-42.92%-42.58M-20.54%-26.01M-94.38%-109.9M-168.13%-35.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List